Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets
Cash and cash equivalents	$ 43,835	$ 56,307
Marketable securities	39,213	46,613
Accounts receivable net of allowance for credit losses of $1,230 and $1,230, respectively	19,120	19,179
Other receivables	3,106	2,526
Inventory	866	866
Prepaid expenses and other current assets	2,087	2,401
Land held for sale	11,282	11,282
Total current assets	119,509	139,174
Property, plant, and equipment, net	211,568	203,919
Operating lease right-of-use asset	3,437	3,735
Intangible assets, net	65	73
Deferred tax assets	563	621
Other long-term assets	13,835	30,505
Total assets	348,977	378,027
Current liabilities
Accounts payable	3,176	2,921
Accrued expenses	6,922	2,779
Operating lease liabilities, current	334	323
Notes payable, short-term	1,730	3,772
Other liabilities, current	410	2,754
Total current liabilities	12,572	12,549
Earnout liability	24	2,486
Canadian Government Research and Development Program liability	14,422	14,399
Common stock warrants liability	1,788	4,566
Notes payable, long-term	1,730	1,730
Operating lease liabilities	3,770	3,858
Other liabilities, long-term	63	74
Total liabilities	34,369	39,662
Commitments and contingencies (See Note 16)
STOCKHOLDERS’ EQUITY
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued and outstanding as of March 31, 2025 and December 31, 2024	0	0
Common stock, $0.0001 par value, 1,000,000,000 shares authorized; 149,506,676 and 148,574,227, issued and outstanding as of March 31, 2025 and December 31, 2024, respectively (including 3,000,000 of Sponsor Vesting Shares)	15	15
Additional paid-in capital	395,475	393,186
Accumulated deficit	(64,568)	(38,127)
Accumulated other comprehensive loss	(16,314)	(16,709)
Total stockholders’ equity	314,608	338,365
Total liabilities and stockholders’ equity	$ 348,977	$ 378,027